Last updated 33 days ago

Depemokimab in Participants With Hypereosinophilic Syndrome, Efficacy, and Safety Trial

120 patients around the world
Available in Spain, United States, Mexico, Argentina, Brazil
GlaxoSmithKline
120Patients around the world
This study is for people with
Hypereosinophilic Syndrome
Requirements for the patient
From 18 Years
All Gender
Medical requirements
Trialtech
About usOur missionOur teamPartnersFAQs
Medical newsLatest newsStudiesInterviewsTestimonials
ProductsUEPM OncoUEPM Physicians
LinksDownloads
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy